DRAFT: This module has unpublished changes.

The molecular biophotonics laboratory develops biomedical optical solutions for diagnostics and therapy.  For example, we are developing techniques to enable point-of-care pathology, a multidisciplinary endeavor that includes the development of advanced microscopic imaging devices, molecularly targeted contrast agents, innovative strategies for quantifying biomarker expression, and reproducible metrics for defining tumor margins in preclinical animal models, and ultimately in humans.  We are also developing spectral-imaging endoscopes, in conjunction with Raman-coded nanoparticle agents, for multiplexed molecular imaging of disease biomarkers.  These projects leverage our multidisciplinary expertise in mechanical engineering, spectroscopy, biomedical optics, molecular imaging, instrumentation, and preclinical/clinical translation. 

 

The lab is directed by Dr. Jonathan Liu.  We have moved to the department of mechanical engineering at the University of Washington (Seattle) in August of 2014. 

 

 

 

 

 

DRAFT: This module has unpublished changes.